Trial NCT00473889

View at ClinicalTrials.gov 
Org. Study IDs: 0683-056
Secondary IDs: 2006_539 MK0683-056

Last trial update was posted on 2015-07-03

MeSH Interventions

Carboplatin Paclitaxel Vorinostat

MeSH Conditions

Carcinoma, Non-Small-Cell Lung Lung Neoplasms

Other Conditions

Stage IIIB or IV Non-Small Cell Lung Cancer

Stopping Reasons

The study was terminated based on the recommendation by the DSMB following a pre-planned protocol interim analysis because the endpoint was not achieved.

Limitations And Caveats

The study was stopped following a pre-planned interim analysis because the goal for this study to continue was not met, based on 100 events, a reduction in the hazard ratio for progression-free survival by > 23% with a one-sided p-value < 0.1

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID